Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

LC Phua, HCW Choi, J Wu, M Jit, J Low, K Ng… - Vaccine, 2021 - Elsevier
Background The nonavalent human papillomavirus (HPV) vaccine has been shown to
extend protection against oncogenic HPV types 31/33/45/52/58 (HPV-OV) not covered by …

[HTML][HTML] Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A

J Qi, L Zhou, D Li, J Yang, H Wang, H Cao, Y Huang… - BMC cancer, 2021 - Springer
Background Cell division cycle 25A (CDC25A) is a well-recognized regulator of cell cycle
progression and is involved in cancer development. This work focused on the function of …

[HTML][HTML] Asian society of gynecologic oncology international workshop 2018

TW Kong, HS Ryu, SC Kim, T Enomoto… - Journal of …, 2019 - synapse.koreamed.org
Abstract The Asian Society of Gynecologic Oncology International Workshop 2018 on
gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to …

Present challenges in cervical cancer prevention: answers from cost-effectiveness analyses

M Diaz, S de Sanjosé, FX Bosch… - Reports of Practical …, 2018 - journals.viamedica.pl
Simulation models are commonly used to address important health policy issues that cannot
be explored through experimental studies. These models are especially useful to determine …

[HTML][HTML] The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia

RA Mahumud, K Alam, J Dunn, J Gow - PLoS One, 2019 - journals.plos.org
Introduction Cervical cancer imposes a substantial health burden worldwide including in
Australia and is caused by persistent infection with one of 13 sexually transmitted high-risk …

Sociodemographic predictors of the human papillomavirus (HPV) and HPV vaccine knowledge and awareness among Americans who use the internet as their …

N Osazuwa-Peters, A Hu, RL Rohde… - Journal of Consumer …, 2018 - Taylor & Francis
We examined differences in HPV and HPV vaccine knowledge among individuals who use
the Internet as their main source of health information versus those who do not. Data were …

Analyzing the cost-effectiveness of Lyme disease risk reduction approaches

RP Behler, N Sharareh, JS Whetten… - Journal of Public Health …, 2020 - Springer
Lyme disease (LD) is endemic in many regions of the Northeastern United States. Given the
elusive nature of the disease, a systematic approach to identify efficient interventions would …

[PDF][PDF] Modelling estimates of the incremental effectiveness & cost-effectiveness of HPV vaccination

M Brisson, M Jit, MC Boily, J Laprise… - … Advisory Group of …, 2016 - terrance.who.int
Modelling estimates of the incremental effectiveness & cost- effectiveness of HPV vaccination
Page 1 1 EXECUTIVE SUMMARY Modelling estimates of the incremental effectiveness & …

[PDF][PDF] Publicly supported family planning services in the united states, 2016: Methodological appendix

JJ Frost, MR Zolna, LF Frohwirth, A Douglas-Hall… - 2019 - guttmacher.org
Contraceptive Needs Page 1 Publicly Supported Family Planning Services in the United
States, 2016: Methodological Appendix Jennifer J. Frost, Mia R. Zolna, Lori F. Frohwirth …

Human papillomavirus vaccine knowledge, beliefs, attitudes, and barriers: A college-based intervention for students to increase knowledge, vaccine intent, and …

SA Siebert - 2018 - search.proquest.com
The purpose of this disquisition was to determine knowledge, beliefs, attitudes, and barriers
of college-age students at North Dakota State University (NDSU) related to the human …